Next-chemx Corporation

NEXT-ChemX Corporation announces a significant debt reduction and restructuring through the issuance of Series B Preferred Stock to two accredited investors, altering control dynamics.

NEXT-ChemX Corporation has appointed Thomas P. Killoran and Ian Carey to its Board of Directors and announced a new corporate address.

NEXT-ChemX Corporation has announced the dismissal of a lawsuit filed against Sparkie Properties LLC, Glenn A. Little, and Empire Stock Transfer Inc., and a favorable ruling in an appeal concerning Benton Wilcoxon v. Sparkie Properties, LLC.

NEXT-ChemX Corporation's CEO and Director, Benton Wilcoxon, resigned effective January 5, 2026, citing shareholder pressure, despite the company's official statement denying disagreements.

NEXT-ChemX Corporation and its Delaware affiliate have initiated three separate lawsuits in Nevada and Delaware against Sparkie Properties, its owner Glenn Little, and transfer agent Empire Stock Transfer, alleging unlawful share conversion, tortious interference, and defamation.

NEXT-ChemX Corporation has authorized and issued 20,000 shares of a new Class F Preferred Stock, with 10,000 shares issued to the president and 10,000 to the Board of Directors.

NEXT-ChemX Corporation filed an amended quarterly report, restating financials due to auditor issues and reclassifying its core technology, while grappling with significant legal challenges and a substantial accumulated deficit.

NEXT-ChemX Corporation filed a restated quarterly report for Q2 2024, revealing significant financial adjustments, ongoing losses, and a legal dispute over 15.8 million shares.

NEXT-ChemX Corporation's latest 10-Q filing reveals significant financial deficiencies, auditor issues, and legal challenges, raising substantial doubt about its ability to continue as a going concern.

NEXT-ChemX Corporation's latest 10-Q/A filing reveals a significant accumulated deficit, ongoing losses, and substantial doubt about its ability to continue as a going concern, compounded by a legal battle over a large block of its common shares.

NEXT-ChemX Corporation files its Q1 2025 report, noting it is unaudited due to auditor transition, while continuing to advance its iTDE technology and facing ongoing legal proceedings.

NEXT-ChemX Corporation's Q3 2024 report is deemed deficient due to the inability of their new auditor to complete a review, while the company also faces legal challenges and going concern doubts.

NEXT-ChemX Corporation's 2024 annual report reveals ongoing financial challenges and operational delays as it strives to commercialize its innovative iTDE technology.

NEXT-ChemX Corporation files an amended 10-K/A report addressing auditor issues, restating financials due to a change in intangible asset valuation, and including a cybersecurity disclosure.

NEXT-ChemX Corporation's 2023 annual report reveals a net loss of $2.36 million and ongoing challenges in securing sufficient funding for its iTDE technology commercialization.

NEXT-ChemX Corporation reported the termination of subscription agreements for Series A and Series F Preferred Stock, which were never executed.

NEXT-ChemX Corporation's President and CFO, John Michael Johnson, reported changes in his beneficial ownership, including the termination of preferred stock subscription agreements and ongoing litigation over common stock ownership.

NEXT-ChemX Corporation's Board of Directors acquired Series A and Series F Preferred Stock, significantly increasing their collective voting power.

NEXT-ChemX Corporation's President and CFO, John Michael Johnson, filed an amended statement detailing his beneficial ownership, including preferred stock acquisitions and disclosing ongoing litigation over share ownership.

NEXT-ChemX Corporation's board member acquires Series F Preferred Stock.

John Michael Johnson, President and CFO of NEXT-ChemX Corporation, reports transactions involving common and preferred stock, including acquisitions of Series A and Series F preferred stock.